Genmab to Acquire Merus, Expanding Late-Stage Pipeline and Accelerating into a Wholly Owned Model
Company Announcement Genmab to acquire Merus for USD 97.00 per share in…
Fermenta Board Approves Sale of Environmental Solutions Business to Wholly Owned Subsidiary
Strategic transfer to enhance operational focus and create dedicated environmental solutions platformTo…
Scilex Holding Company Announces Deferral of Record Date for its Previously Announced Dividend of Preferred Stock Exchangeable for up to 10% of Scilexs Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary from May 2, 2025 to a f
June 23, 2025 16:50 ET | Source: Scilex Holding Company PALO ALTO,…
FIS accelerates its digital transformation with record growth across owned platforms
Jun 06, 2025 – As part of its long-term commitment to grow…
